1. Home
  2. LMAT vs IRON Comparison

LMAT vs IRON Comparison

Compare LMAT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

N/A

Current Price

$109.16

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$66.23

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LMAT
IRON
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
LMAT
IRON
Price
$109.16
$66.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
$105.80
$101.67
AVG Volume (30 Days)
217.1K
969.9K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
0.92%
N/A
EPS Growth
30.57
N/A
EPS
2.52
N/A
Revenue
$249,602,000.00
N/A
Revenue This Year
$13.66
N/A
Revenue Next Year
$8.97
$101.57
P/E Ratio
$43.32
N/A
Revenue Growth
13.53
N/A
52 Week Low
$71.42
$30.82
52 Week High
$115.33
$99.50

Technical Indicators

Market Signals
Indicator
LMAT
IRON
Relative Strength Index (RSI) 65.18 46.23
Support Level $81.51 $57.45
Resistance Level $115.33 $69.36
Average True Range (ATR) 4.19 2.93
MACD 0.58 0.55
Stochastic Oscillator 69.78 64.28

Price Performance

Historical Comparison
LMAT
IRON

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: